Skip to main content
OpenTrials
Completed

NCT Number: NCT00100100

Modafinil for the Treatment of Cocaine Dependence - 1

The purpose of this study is to evaluate the efficacy and safety of modafinil in reducing cocaine use in subjects with cocaine dependence.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Cocaine-Related Disorders Chemically-Induced Disorders Mental Disorders Substance-Related Disorders

Age range

18 year–99 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 2

Primary location

Boston University Medical Center, Boston, Massachusetts, United States

Loading trial locations.

About this study

This is a double-blind, placebo-controlled, parallel group design study to evaluate the efficacy and safety of modafinil in reducing cocaine use in subjects with cocaine dependence.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Participant must have DSM-IV diagnosis of cocaine dependence as determined by SCID.
  • Must be seeking treatment for cocaine dependence.
  • Must be able to understand and provide written informed consent.

Exclusion criteria

  • Please contact the study site for more information.

Treatment and study plan

Modafinil

Drug

Primary outcomes

  1. Cocaine abstinence

Sponsors and collaborators

Lead sponsor

National Institute on Drug Abuse (NIDA)

Nih

Registry information

Official study title

Modafinil for the Treatment of Cocaine Dependence

Important dates

Study start
2004
Study completion
2006
First posted
Dec 23, 2004
Registry last updated
Jan 12, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.